Aaron E. Katz, MD | Grand Rounds in Urology

Aaron E. Katz, MD, FACS

Winthrop-University Hospital

Mineola, New York

Dr. Aaron E. Katz is currently Chairman of Urology at Winthrop University Hospital and Professor of Urology at NYU Long Island School of Medicine. Prior to his arrival at Winthrop, he had served as a faculty member at Columbia University since 1993. During his tenure at Columbia, he held the title of Carl A. Olsson Professor of Urology and Director of the Center for Holistic Urology, which he established in 1998.

Recently, Dr. Katz started a Urology Residency at NYU Winthrop and is currently the Program Director. He is also currently serving as the Principle Investigator for numerous clinical trials. Dr. Katz is recognized as an expert in the field of prostate cryosurgery. His pioneering work in advancing this technology helped Medicare approve this therapy for treating radiation-recurrent tumors. In the field of cryosurgery, he has published numerous articles, written chapters for medical textbooks, and directed courses at both regional and national levels.

To date, Dr. Katz has published over 130 scientific articles in peer-reviewed journals, and has written four chapters for urologic textbooks. He is the author of two recently published books: “The Definitive Guide to Prostate Cancer” and “Dr. Katz’s Guide to Prostate Health: From Conventional to Holistic.” Dr. Katz is also the host of a weekly radio show on men’s health on WABC in New York called “Katz’s Corner.”

Disclosures:

Articles by Aaron E. Katz, MD, FACS

Evaluation and Management of Recurrent Prostate Cancer Following Radiation Therapy

Posted by Aaron E. Katz, MD, FACS | Jul 2020

Aaron Katz, MD, FACS, Chairman of Urology at Winthrop University Hospital and Professor of Urology at NYU Long Island School of Medicine, discusses the ins and outs of various salvage therapies for the treatment of patients that have failed primary radiation treatment. He begins by discussing different methods of patient selection for salvage therapy, including differentiation of isolated local recurrence versus systemic spread, patient age, and comorbidities, as well as the proper steps in conducting thorough patient history and workup. Next, Dr. Katz reviews several non-curative and potentially curative salvage therapy options and discusses the impact these therapies have on relative quality of life, in addition to their relative 5 and 10-year biochemical free survival rates. He concludes with a patient case study along with data from numerous single and multi-institution studies that demonstrate the relative quality of life impacts as well as relative 5 and 10-year disease-specific survival rates for these salvage procedures.